![]() Alcobra Alcobra is a pharmaceutical company developing new medications to help patients with cognitive disorders, including ADHD and Fragile X Syndrome. | ![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | |
Founding Date | Founding Date 2008 | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tel Aviv-Yafo, IL HQ | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | Locations Heidelberg, DE HQ |
Employees | Employees 19 | Employees 3218% decrease | Employees 76 |
Valuation ($) | Valuation ($) 5.7 m | Valuation ($) 49.7 m | Valuation ($) 52.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €33.2m (FY, 2022) | Revenue (est.) €8.3m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods €382k (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €33.4m (FY, 2022) | Gross profit €13m (FY, 2023) |
Net income | Net income N/A | Net income (€579k) (FY, 2022) | Net income (€105.9m) (FY, 2023) |

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company